RecruitingPhase IIIMale onlyEN originalProstate cancer

PSMA PET Combined With MRI for the Detection of PCa

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Mężczyzna w wieku co najmniej 18 lat
  • Podejrzenie raka prostaty potwierdzające się MRI lub podwyższonym PSA, gęstością PSA lub anomaliami w badaniu
  • Silna rodzinna historia raka prostaty (ojciec, brat lub bliscy krewni)
  • Nigdy wcześniej nie miał biopsji prostaty
  • Zdolność do zrozumienia i wykonywania wymogów badania
  • Zgoda na przeprowadzenie biopsji prostaty

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 23, 2026
Sex
Male only

Therapies / drugs in trial

Locations (18)

University of California Los Angeles

Los Angeles, United States

University of California San Francisco

San Francisco, United States

Impression Imaging

Boca Raton, United States

University of Miami

Miami, United States

UroPartners,LLC

Chicago, United States

Indiana University

Indianapolis, United States

Southern Urology

Lafayette, United States

Ochsner Clinic Foundation

New Orleans, United States

Washington University

St Louis, United States

Weill Cornell

New York, United States

MidLantic Urology

Philadelphia, United States

Atlantic Urology Specialists

Myrtle Beach, United States

The Conrad Pearson Clinic

Germantown, United States

Urology Associates of Nashville

Nashville, United States

Urology Austin

Austin, United States

Urology of Virginia

Virginia Beach, United States

Australian Prostate Centre

Melbourne N., Australia

St Vincent's Hospital Sydney

Sydney, Australia

Trial contact

Professor Anthony Costello, Urologist

PRINCIPAL_INVESTIGATOR

Mr Phillip Dundee, Urology Surgeon

SUB_INVESTIGATOR

Professor Rodney Hicks

SUB_INVESTIGATOR

Professor Louise Emmett

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/24/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.